AR034037A1 - Inhibidor de aromatasa en dosis multiples para tratar la infertilidad - Google Patents
Inhibidor de aromatasa en dosis multiples para tratar la infertilidadInfo
- Publication number
- AR034037A1 AR034037A1 ARP020101400A ARP020101400A AR034037A1 AR 034037 A1 AR034037 A1 AR 034037A1 AR P020101400 A ARP020101400 A AR P020101400A AR P020101400 A ARP020101400 A AR P020101400A AR 034037 A1 AR034037 A1 AR 034037A1
- Authority
- AR
- Argentina
- Prior art keywords
- daily doses
- aromatase inhibitor
- hormone
- administering
- folliculostimulant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un método para inducir la ovulación de un sujeto de sexo femenino que sufre de infertilidad anovulatoria que comprende administrar a dicho sujeto dos o más dosis diarias de al menos un inhibidor de aromatasa. Un método para aumentar la ovulación en un sujeto de sexo femenino que sufre de infertilidad sin causa aparente u otro tipo de infertilidad anovulatoria que comprende administrar a dicho sujeto de sexo femenino una combinación de dos o más dosis diarias de al menos un inhibidor de aromatasa en uno o más ciclos menstruales. Un método para reducir sustancialmente los niveles de dosificación de hormona folículostimulante (FSH) para administrar a una mujer que comprende administrar una combinación de dos o más dosis diarias de por lo menos un inhibidor de aromatasa (AI) con varias dosis diarias de hormona foliculostimulante (FSH). Un método para aumentar la respuesta a la hormona foliculostimulante de una mujer que tiene un bajo nivel de respuesta a la estimulación del folículo, que comprende administrar una combinación de dos o más dosis diarias de por lo menos un inhibidor de aromatasa (AI) con varias dosis diarias de hormona foliculostimulante (FSH). También se incluyen preparaciones farmacéuticas y usos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA2001/000517 WO2002083146A1 (en) | 2001-04-17 | 2001-04-17 | Multiple dose aromatase inhibitor for treating infertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034037A1 true AR034037A1 (es) | 2004-01-21 |
Family
ID=4143137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101400A AR034037A1 (es) | 2001-04-17 | 2002-04-17 | Inhibidor de aromatasa en dosis multiples para tratar la infertilidad |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7820706B2 (es) |
| AR (1) | AR034037A1 (es) |
| BR (1) | BR0208955A (es) |
| CA (1) | CA2472309C (es) |
| MX (1) | MXPA03009448A (es) |
| WO (2) | WO2002083146A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007056851A1 (en) * | 2005-11-17 | 2007-05-24 | Mount Sinai Hospital | Compositions and methods for enhancing ovulation inducing agents |
| US20100087407A1 (en) * | 2006-08-04 | 2010-04-08 | James Symons | use of aromatase inhibitors |
| NZ603548A (en) * | 2010-05-20 | 2014-06-27 | Univ Saskatchewan | Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal |
| US10004723B2 (en) | 2013-04-19 | 2018-06-26 | University Of Saskatchewan | Aromatase inhibitor-releasing intravaginal device |
| RU2527166C1 (ru) * | 2013-07-26 | 2014-08-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РостГМУ Минздрава России) | Способ моделирования синдрома хронической ановуляции |
| US20200011883A1 (en) * | 2017-02-17 | 2020-01-09 | Celmatix Inc. | Methods for assessing the probability of achieving ongoing pregnancy and informing treatment therefrom |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845227A (en) * | 1984-06-18 | 1989-07-04 | Eli Lilly And Company | Aromatase inhibitors from azoles |
| DE4330237C2 (de) * | 1993-09-02 | 1995-11-30 | Schering Ag | 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
| DE4330023C2 (de) | 1993-09-06 | 2001-11-29 | Koenig & Bauer Ag | Vorrichtung zum Klemmen und Spannen einer biegsamen Druckplatte |
| DE19622457A1 (de) | 1996-05-24 | 1997-11-27 | Schering Ag | 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
| US6953774B2 (en) * | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
-
2001
- 2001-04-17 US US10/475,175 patent/US7820706B2/en not_active Expired - Fee Related
- 2001-04-17 WO PCT/CA2001/000517 patent/WO2002083146A1/en active Application Filing
- 2001-04-17 CA CA2472309A patent/CA2472309C/en not_active Expired - Fee Related
-
2002
- 2002-04-17 AR ARP020101400A patent/AR034037A1/es unknown
- 2002-04-17 BR BR0208955-6A patent/BR0208955A/pt not_active IP Right Cessation
- 2002-04-17 WO PCT/CA2002/000520 patent/WO2002083239A1/en not_active Application Discontinuation
- 2002-04-17 MX MXPA03009448A patent/MXPA03009448A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7820706B2 (en) | 2010-10-26 |
| MXPA03009448A (es) | 2004-05-24 |
| CA2472309C (en) | 2010-12-07 |
| US20040235804A1 (en) | 2004-11-25 |
| WO2002083239A1 (en) | 2002-10-24 |
| WO2002083146A1 (en) | 2002-10-24 |
| CA2472309A1 (en) | 2002-10-24 |
| BR0208955A (pt) | 2004-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR6458A (es) | Composiciones de valdecoxib | |
| BR9306042A (pt) | Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável | |
| BR0115392A (pt) | Método para o tratamento de uma doença sensìvel a interferona em um animal de sangue quente, método para individualizar as dosagens de uma interferona no tratamento, método para a fabricação de um dispositivo de liberação de efeito terapêutico de longa duração de uma droga ao longo de um perìodo de tempo, e conjunto útil para a ministração de uma quantidade relativamente constante de uma droga | |
| BR0115109A (pt) | Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese | |
| AR032912A1 (es) | Formulacion farmaceutica | |
| DK1011653T3 (da) | Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser | |
| AR034813A1 (es) | Composiciones farmaceuticas y uso de las mismas | |
| HUP0302913A2 (hu) | Eljárások ráksejt-halál és tumor visszafejlődés indukálására és ezek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| AR034037A1 (es) | Inhibidor de aromatasa en dosis multiples para tratar la infertilidad | |
| CY1108648T1 (el) | Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας | |
| AR010623A1 (es) | Paquete de asistencia al paciente y metodo para el cumplimiento de tratamientos complejos de medicinas | |
| Tredway et al. | Anastrozole versus clomiphene citrate: which is better for ovulation induction? | |
| AR014082A1 (es) | Concentrado oral de sertralina | |
| AR034310A1 (es) | Inhibicion de aromatasa para mejorar la reproduccion asistida | |
| ATE283059T1 (de) | Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit | |
| WO2002074315A8 (de) | Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie | |
| AR042308A1 (es) | Medicamento de administracion transdermica y transmucosica con absorcion mejorada de principios activos | |
| BR112022026086A2 (pt) | Métodos para tratar câncer ou doença de von-hippel lindau e para tratar carcinoma de célula renal, kit, e, uso de uma combinação terapêutica | |
| Li | Local use of iontophoresis with traditional Chinese herbal medicine, eg, Gu-Sui-Bu (Rhizoma Drynariae) may accelerate orthodontic tooth movement | |
| AR023464A1 (es) | Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados | |
| AR027677A1 (es) | Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer | |
| Davar et al. | Comparison of the success rate of letrozole and clomiphene citrate in women undergoing intrauterine insemination | |
| KR930702016A (ko) | 골다공증 치료제 | |
| AR016308A1 (es) | Uso de inhibidores de la fosfodiesterasa 4 o sus sales, medicamento para el tratamiento de la rinitis alergica que contiene los compuestos mencionados yprocedimiento para preparar dicho medicamento. | |
| BR9809124A (pt) | Combinação, formulação, farmacêutica, processo para o tratamento de uma infecção por hiv em um animal, infectado, uso de (-)-(1s, 4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-cicl openteno-1-metanol, e, pacote de paciente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |